QuidelOrtho Stock
QuidelOrtho Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- United States
- CEO
- Brian J. Blaser
- Employees
- 6,500
- Market cap
- $885 M
- IPO
- 01/02/1991
QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily…
QuidelOrtho stock: price history
1D
-7.2%
1W
-3.8%
1M
+19.9%
6M
+1.6%
YTD
-54.8%
1Y
-54.6%
2Y
-67.7%
5Y
-89.9%
10Y
-38.9%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~112% stronger price swings than usual
Ask the agents about QuidelOrtho
Analyst assessment of QuidelOrtho
PRICE TARGET LOW
US$12.00
CONSENSUS
US$12.25
MEDIAN
US$12.25
PRICE TARGET HIGH
US$12.50
0
STRONG BUY
6
BUY
7
HOLD
2
SELL
0
STRONG SELL
15
TOTAL · Hold
As of: 08/07/2026
QuidelOrtho stock metrics
P/E
-0.84
P/B
0.5
EV/EBITDA
-10.04
RETURN ON EQUITY
-5.2%
NET MARGIN
-14.7%
DEBT/EQUITY
1.73
DIVIDEND YIELD
0.0%
AS OF
28/06/2026
Free float & liquidity
FREE FLOAT
99.1%
FLOAT SHARES
67,961,376
AVG. DAILY VOLUME (30D)
1,912,308
Insider transactions (SEC)
Bowman Ronald Lee
Bowman Ronald Lee
Hanson Bryan Michael
Hanson Bryan Michael
Hanson Bryan Michael
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -7.2%
Forums (Reddit)
Institutional holders
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about QuidelOrtho stock
What does QuidelOrtho do?
QuidelOrtho Corporation is a company in the Healthcare sector, Medical - Specialties industry, headquartered in United States.
The CEO is Brian J. Blaser, the company employs around 6,500 people.
The IPO was on 01/02/1991; the stock trades on NASDAQ under the ticker QDEL.
What do analysts say about QuidelOrtho stock?
15 analysts rate the stock, the consensus is Hold (as of 08/07/2026).
The average price target is US$12.25, ranging from US$12.00 to US$12.50, with a median of US$12.25.
This is an external assessment, not a statement by Market Jury.
When does QuidelOrtho report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 112% stronger than usual.
Does QuidelOrtho pay a dividend?
No, QuidelOrtho currently does not pay a dividend.
Which stocks are comparable to QuidelOrtho?
Comparable stocks include STERIS, Mesa Laboratories, 908 Devices, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson, AbbVie and Merck &.
How can I get QuidelOrtho stock analyzed?
Clicking "Analyze stock" lets five strategies assess QuidelOrtho against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.